Status: Recruiting
A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
A prospective, 180-day, randomized, multicenter, independent blinded evaluators, controlled study of treatment with the Thermage FLX System
Participants needed: 164
Trial details
Age: 30-60Biological sex: AllType: InterventionalSponsor: Bausch Health Americas, Inc.Updated: Dec 17, 2025Locations: 1
Eligibility criteria
Be an adult female or male, ≥30 - ≤60 years of age.
Participant is pregnant or breast feeding or trying to become pregnant for 3 mon...